Aciclovir elaidate

Drug Profile

Aciclovir elaidate

Alternative Names: P 4010

Latest Information Update: 30 Aug 2002

Price : $50

At a glance

  • Originator Norsk Hydro
  • Developer Nonindustrial source
  • Class Antivirals
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Herpes simplex virus infections

Most Recent Events

  • 30 Jul 1999 New profile
  • 30 Jul 1999 Preclinical development for Herpes simplex virus infections in United Kingdom (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top